COMPANY
Clinical Phase 2
Keywords: neurology immunology Weight Management GV101
Location: New York, NY · source · Feb 14, 2024
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 2: GV101 in Healthy Obese Participants source ↗
- Trial start Phase 1: Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06979505 | GV101 in Healthy Obese Participants | Phase 2 | Completed | Jun 30, 2025 | Jan 28, 2026 (actual) |
| NCT05068947 | Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects | Phase 1 | Completed | Sep 10, 2021 | Oct 22, 2021 (actual) |
